Headache and hypertension. Myth and evidence;Kopfschmerzund bluthochdruck. Mythos und evidenz

Nervenarzt

Volumn 81, Issue 8, 2010, Pages 963-972

  Liman, T ^a   Siebert, E ^a   Endres, M ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Headache; Hypertension; Hypertensive encephalopathy; Posterior reversible encephalopathy syndrome

Indexed keywords

BRAIN; BRAIN EDEMA; CHRONIC DISEASE; DIFFERENTIAL DIAGNOSIS; DIFFUSION WEIGHTED IMAGING; HEADACHE; HUMAN; HYPERTENSION; HYPERTENSION ENCEPHALOPATHY; LITERATURE; MALIGNANT HYPERTENSION; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; REVIEW;

BRAIN; BRAIN EDEMA; CHRONIC DISEASE; DIAGNOSIS, DIFFERENTIAL; DIFFUSION MAGNETIC RESONANCE IMAGING; HEADACHE; HUMANS; HYPERTENSION; HYPERTENSION, MALIGNANT; HYPERTENSIVE ENCEPHALOPATHY; MAGNETIC RESONANCE IMAGING; MYTHOLOGY;

EID: 79952110572     PISSN: 00282804     EISSN: 14330407     Source Type: Journal    
DOI: 10.1007/s00115-010-2996-6     Document Type: Review

References (84)

1. Chatellier G et al (1982) Symptom prevalence in hypertensive patients. Eur Heart J 3[Suppl C]:45-52 (Pubitemid 13200400)
2. Di Tullio M et al (1988) Prevalence of symptoms generally attributed to hypertension or its treatment: study on blood pressure in elderly outpatients (SPAA). J Hypertens [Suppl 6](1):87-90
3. Featherstone HJ (1985) Medical diagnoses and problems in individuals with recurrent idiopathic headaches. Headache 25(3):136-140
4. Moser M, Wish H, Friedman AP (1962) Headache and hypertension. JAMA 180:301-306
5. Stewart IM (1953) Headache and hypertension. Lancet 1(6774):1261-1266
6. Waters WE (1971) Headache and blood pressure in the community. Br Med J 1(5741):142-143
7. Weiss NS (1972) Relation of high blood pressure to headache, epistaxis, and selected other symptoms. The united states health examination survey of adults. N Engl J Med 287(13):631-633
8. Schele R, Ahlborg B, Ekbom K (1978) Physical characteristics and allergic history in young men with migraine and other headaches. Headache 18(2):80-86 (Pubitemid 8318675)
9. Kottke TE et al (1979) The relationship of symptoms and blood pressure in a population sample. Int J Epidemiol 8(4):355-359 (Pubitemid 10173978)
10. Paulin JM et al (1985) The prevalence of headache in a small New Zealand town. Headache 25(3):147-151 (Pubitemid 15031481)
11. Chen TC et al (1987) Migraine and other diseases in women of reproductive age. The influence of smoking on observed associations. Arch Neurol 44(10):1024-1028
12. Rasmussen BK, Olesen J (1992) Symptomatic and nonsymptomatic headaches in a general population. Neurology 42(6):1225-1231
13. Ho KH, Benjamin KC (2001) Perceived headache associations in Singapore: results of a randomized national survey. Headache 41(2):164-170
14. Gus M et al (2001) Behavior of ambulatory blood pressure surrounding episodes of headache in mildly hypertensive patients. Arch Intern Med 161(2):252-255 (Pubitemid 32102393)
15. Kruszewski P et al (2000) Headache in patients with mild to moderate hypertension is generally not associated with simultaneous blood pressure elevation. J Hypertens 18(4):437-444 (Pubitemid 30209726)
16. IHS (1988) Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Headache classification committee of the international headache society. Cephalalgia 8[Suppl 7]:1-96
17. IHS (2004) The international classification of headache disorders: 2nd edn. Cephalalgia 24[Suppl 1]:9-160
18. JNC (1997) The sixth report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure. Arch Intern Med 157(21):2413-2446
19. Fuchs FD et al (2003) Headache is not more frequent among patients with moderate to severe hypertension. J Hum Hypertens 17(11):787-790 (Pubitemid 37441436)
20. Janeway T (1913) A clinical study of hypertensive cardiovascular disease. Arch Intern Med 12:755-798
21. Bulpitt CJ, Dollery CT, Carne S (1976) Change in symptoms of hypertensive patients after referral to hospital clinic. Br Heart J 38(2):121-128
22. Cooper WD et al (1989) Headache and blood pressure: evidence of a close relationship. J Hum Hypertens 3(1):41-44 (Pubitemid 19098721)
23. Brater DC (1996) Benefits and risks of torasemide in congestive heart failure and essential hypertension. Drug Saf 14(2):104-120
24. Brogden RN, Wiseman LR (1998) Moexipril. A review of its use in the management of essential hypertension. Drugs 55(6):845-860 (Pubitemid 28256999)
25. Lee CR, Bryson HM (1994) Lacidipine. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential in the treatment of hypertension. Drugs 48(2):274-296 (Pubitemid 24260358)
26. Hansson L et al (2000) Headache in mild-to-moderate hypertension and its reduction by irbesartan therapy. Arch Intern Med 160(11):1654-1658 (Pubitemid 30367904)
27. Bensenor IJ et al (2002) Blood pressure behaviour in chronic daily headache. Cephalalgia 22(3):190-194 (Pubitemid 34556992)
28. Wiehe M et al (2002) Migraine is more frequent in individuals with optimal and normal blood pressure: a population-based study. J Hypertens 20(7):1303-1306 (Pubitemid 34925674)
29. Hagen K et al (2002) Blood pressure and risk of headache: a prospective study of 22 685 adults in Norway. J Neurol Neurosurg Psychiatry 72(4):463-466
30. Pietrini U, De Luca M, De Santis G (2005) Hypertension in headache patients? A clinical study. Acta Neurol Scand 112(4):259-264 (Pubitemid 41337075)
31. Duley L (2009) The global impact of pre-eclampsia and eclampsia. Semin Perinatol 33(3):130-137
32. Vaughan CJ, Delanty N (2000) Hypertensive emergencies. Lancet 356(9227):411-417 (Pubitemid 30487503)
33. Blackwell B, Mabbitt LA (1965) Tyramine in cheese related to hypertensive crises after monoamineoxidase inhibition. Lancet 1(7392):938-940
34. Littlewood JT et al (1988) Red wine as a cause of migraine. Lancet 1(8585):558-559 (Pubitemid 18060480)
35. Oppenheimer BS, Fishberg AM (1928) Hypertensive encephalopathy. Arch Intern Med 41(2):264-278
36. Schwartz RB (2002) Hyperperfusion encephalopathies: hypertensive encephalopathy and related conditions. Neurologist 8(1):22-34
37. Mirza A (2006) Posterior reversible encephalopathy syndrome: a variant of hypertensive encephalopathy. J Clin Neurosci 13(5):590-595
38. Pavlakis SG, Frank Y, Chusid R (1999) Hypertensive encephalopathy, reversible occipitoparietal encephalopathy, or reversible posterior leukoencephalopathy: three names for an old syndrome. J Child Neurol 14(5):277-281 (Pubitemid 29239182)
39. Bartynski WS (2008) Posterior reversible encephalopathy syndrome, part 2: controversies surrounding pathophysiology of vasogenic edema. AJNR Am J Neuroradiol 29(6):1043-1049
40. Aaslid R (2006) Cerebral autoregulation and vasomotor reactivity. Front Neurol Neurosci 21:216-228
41. Byrom FB (1954) The pathogenesis of hypertensive encephalopathy and its relation to the malignant phase of hypertension; experimental evidence from the hypertensive rat. Lancet 267(6831):201-211
42. Sheth RD et al (1996) Parietal occipital edema in hypertensive encephalopathy: a pathogenic mechanism. Eur Neurol 36(1):25-28
43. Edvinsson L, Hardebo JE, Owman C (1978) Influence of the cerebrovascular sympathetic innervation on regional flow, autoregulation, and blood-brain barrier function. Ciba Found Symp 1978(56):69-95
44. Zhang R et al (2002) Autonomic neural control of dynamic cerebral autoregulation in humans. Circulation 106(14):1814-1820
45. Kumai Y et al (2002) Hypertensive encephalopathy extending into the whole brainstem and deep structures. Hypertens Res 25(5):797-800 (Pubitemid 35153770)
46. Casey SO et al (2000) Posterior reversible encephalopathy syndrome: utility of fluid-attenuated inversion recovery MR imaging in the detection of cortical and subcortical lesions. AJNR Am J Neuroradiol 21(7):1199-1206 (Pubitemid 30655653)
47. Covarrubias DJ, Luetmer PH, Campeau NG (2002) Posterior reversible encephalopathy syndrome: prognostic utility of quantitative diffusion-weighted MR images. AJNR Am J Neuroradiol 23(6):1038-1048 (Pubitemid 34663453)
48. Schwartz RB et al (1998) Diffusion-weighted MR imaging in hypertensive encephalopathy: clues to pathogenesis. AJNR Am J Neuroradiol 19(5):859-862 (Pubitemid 30415767)
49. Ille O et al (1995) Hypertensive encephalopathy after bilateral carotid endarterectomy. Stroke 26(3):488-491
50. Hinchey J et al (1996) A reversible posterior leukoencephalopathy syndrome. N Engl J Med 334(8):494-500 (Pubitemid 26067737)
51. Bartynski WS (2008) Posterior reversible encephalopathy syndrome, part 1: fundamental imaging and clinical features. AJNR Am J Neuroradiol 29(6):1036-1042
52. Savvidou MD et al (2003) Endothelial dysfunction and raised plasma concentrations of asymmetric dimethylarginine in pregnant women who subsequently develop pre-eclampsia. Lancet 361(9368):1511-1517 (Pubitemid 36566342)
53. Nuver J et al (2010) Vascular damage in testicular cancer patients: a study on endothelial activation by bleomycin and cisplatin in vitro. Oncol Rep 23(1):247-253
54. Benigni A et al (1992) The acute effect of FK506 and cyclosporine on endothelial cell function and renal vascular resistance. Transplantation 54(5):775-780
55. Der H et al (2007) Impaired endothelial function and increased carotid intima-media thickness in association with elevated von Willebrand antigen level in primary antiphospholipid syndrome. Lupus 16(7):497-503 (Pubitemid 47242523)
56. Bartynski WS, Boardman JF (2008) Catheter angiography, MR angiography, and MR perfusion in posterior reversible encephalopathy syndrome. AJNR Am J Neuroradiol 29(3):447-455 (Pubitemid 351424055)
57. Ducros A et al (2007) The clinical and radiological spectrum of reversible cerebral vasoconstriction syndrome. A prospective series of 67 patients. Brain 130(12):3091-3101 (Pubitemid 350209073)
58. Zampaglione B et al (1996) Hypertensive urgencies and emergencies. Prevalence and clinical presentation. Hypertension 27(1):144-147 (Pubitemid 26017693)
59. Henderson RD et al (2003) Posterior leukoencephalopathy following intrathecal chemotherapy with MRA-documented vasospasm. Neurology 60(2):326-328 (Pubitemid 36152032)
60. McKinney AM et al (2007) Posterior reversible encephalopathy syndrome: incidence of atypical regions of involvement and imaging findings. AJR Am J Roentgenol 189(4):904-912 (Pubitemid 47485623)
61. Lee VH et al (2008) Clinical spectrum of reversible posterior leukoencephalopathy syndrome. Arch Neurol 65(2):205-210 (Pubitemid 351240781)
62. Idilman R et al (1998) Immunosuppressive drug-induced leukoencephalopathy in patients with liver transplant. Eur J Gastroenterol Hepatol 10(5):433-436 (Pubitemid 28241433)
63. Ikeda M et al (2001) Reversible posterior leukoencephalopathy in a patient with minimal-change nephrotic syndrome. Am J Kidney Dis 37(4):E30
64. Kim BS et al (2001) Posterior leukoencephalopathy syndrome during steroid therapy in a down syndrome patient with nephrotic syndrome. Nephron 87(3):289-290 (Pubitemid 32268575)
65. Kawano H et al (2002) [Reversible posterior leukoencephalopathy syndrome in two patients with microscopic polyarteritis nodosa]. Rinsho Shinkeigaku 42(10):949-953
66. Utsumi K et al (2003) Acute posterior leukoencephalopathy in a patient with nephrotic syndrome. Clin Exp Nephrol 7(1):63-66 (Pubitemid 36460544)
67. Ohta T et al (2004) Reversible posterior leukoencephalopathy in a patient with Wegener granulomatosis. Pediatr Nephrol 19(4):442-444 (Pubitemid 38477410)
68. Irvin W et al (2007) Dexamethasone-induced posterior reversible encephalopathy syndrome. J Clin Oncol 25(17):2484-2486 (Pubitemid 46999222)
69. Lewis M, Maddison P (2000) Intravenous immunoglobulin causing reversible posterior leukoencephalopathy syndrome? J Neurol Neurosurg Psychiatry 69(5):704
70. Tajima Y et al (1999) Two similar cases of encephalopathy, possibly a reversible posterior leukoencephalopathy syndrome: serial findings of magnetic resonance imaging, SPECT and angiography. Intern Med 38(1):54-58
71. Kamar N et al (2001) Reversible posterior leukoencephalopathy syndrome in hepatitis C virus-positive long-term hemodialysis patients. Am J Kidney Dis 37(4): E29
72. Nagel S et al (2007) Linezolid-induced posterior reversible leukoencephalopathy syndrome. Arch Neurol 64(5):746-748 (Pubitemid 46789843)
73. Giner V et al (2002) Reversible posterior leukoencephalopathy secondary to indinavir-induced hypertensive crisis: a case report. Am J Hypertens 15(5):465-467 (Pubitemid 34478487)
74. Sueblinvong T et al (2002) Posterior leukoencephalopathy following cisplatin, bleomycin and vinblastine therapy for germ cell tumor of the ovary. J Obstet Gynaecol Res 28(2):99-103 (Pubitemid 34732561)
75. Dzudie A et al (2009) Cyclosporine-related posterior reversible encephalopathy syndrome after heart transplantation: should we withdraw or reduce cyclosporine?: case reports. Transplant Proc 41(2):716-720
76. Nishigaki Y et al (1999) [Reversible posterior leukoencephalopathy in a patient receiving cyclosporin therapy]. Rinsho Shinkeigaku 39(2-3):360-363
77. Paul F et al (2006) [Relapsing reversible posterior leukoencephalopathy after chemotherapy with cisplatin and 5-fluorouracil]. Nervenarzt 77(6):706-710
78. Grimbert P et al (1999) Tacrolimus (FK506)-induced severe and late encephalopathy in a renal transplant recipient. Nephrol Dial Transplant 14(10):2489-2491 (Pubitemid 29462496)
79. Nakazato T et al (2003) Reversible posterior leukoencephalopathy syndrome associated with tacrolimus therapy. Intern Med 42(7):624-625
80. Legriel S et al (2008) Lysergic acid amide-induced posterior reversible encephalopathy syndrome with status epilepticus. Neurocrit Care 9(2):247-252
81. Rodriguez Gomez E et al (2001) [Reversible posterior leukoencephalopathy, severe hypertension, and cocaine abuse]. Nefrologia 21(3):305-308
82. Honkaniemi J et al (2000) Reversible posterior leukoencephalopathy after combination chemotherapy. Neuroradiology 42(12):895-899 (Pubitemid 32015617)
83. Ito Y et al (1998) Cisplatin neurotoxicity presenting as reversible posterior leukoencephalopathy syndrome. AJNR 19(3):415-417 (Pubitemid 30422741)
84. Bodkin CL, Eidelman BH (2007) Sirolimus-induced posterior reversible encephalopathy. Neurology 68(23):2039-2040 (Pubitemid 46869711)